New: Instantly spot drawdowns, dips, insider moves, and breakout themes across Maps and Screener.

Creative Medical Technology Holdings, Inc.

Contributing Author

Recent Articles by Creative Medical Technology Holdings, Inc.

Jan-13	Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain CELZ GlobeNewswire
Jan-06	Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative CELZ GlobeNewswire
Dec-17	Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point CELZ GlobeNewswire
Dec-02	Creative Medical Technology Holdings Announces World Health Organization Approval of "olastrocel" as INN for Lead Allogeneic Cell Therapy CELZ-201 CELZ GlobeNewswire
Oct-30	Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits CELZ GlobeNewswire
Oct-29	Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds CELZ GlobeNewswire
Oct-27	Creative Medical Technology Holdings Issues Letter to Shareholders CELZ GlobeNewswire
Oct-07	Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs CELZ GlobeNewswire
Aug-13	Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain CELZ GlobeNewswire
Jul-17	Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells CELZ GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.